ImmunityBio, Inc. — Director's Dealing 2019

Sep 9, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2019-09-05

Reporting Person: Thomas John C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-05	Common Stock	S	2964	$1.25	Disposed	391105	Direct
2019-09-06	Common Stock	S	7080	$1.24	Disposed	384025	Direct
2019-09-09	Common Stock	S	13956	$1.24	Disposed	370069	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	13886	Indirect

Footnotes

F1: Reported shares held by the John C Thomas Jr. Trustee Susan T Thomas U/W DTD 5/10/96.